Anjana Rao

Anjana Rao

Auto-generated profile, based on publicly available information

Anjana Rao

Division of Signaling and Gene Expression, La Jolla Institute for Immunology, La Jolla, CA 92037, USA

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2019 in Nature Reviews Immunology
Verified
Journal Article
Closed access
PDF file
CBChristian U. Blank
Christian U. Blank
WHW. Nicholas Haining
W. Nicholas Haining
WHWerner Held
Werner Held
PHPatrick G. Hogan
Patrick G. Hogan
AKAxel Kallies
Axel Kallies
DZDietmar Zehn
Dietmar Zehn

27 February 2019 in Nature
Verified
Journal Article
Closed access
PDF file
JCJoyce Chen
Joyce Chen
ILIsaac F. López-Moyado
Isaac F. López-Moyado
HSHyungseok Seo
Hyungseok Seo
CLChan-Wang J. Lio
Chan-Wang J. Lio
LHLaura J. Hempleman
Laura J. Hempleman
ARAnjana Rao
Anjana Rao

31 May 2019 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
HSHyungseok Seo
Hyungseok Seo
JCJoyce Chen
Joyce Chen
EGEdahí González-Avalos
Edahí González-Avalos
DSDaniela Samaniego-Castruita
Daniela Samaniego-Castruita
ADArundhoti Das
Arundhoti Das
ARAnjana Rao
Anjana Rao
T cells expressing chimeric antigen receptors (CAR T cells) have shown impressive therapeutic efficacy against leukemias and lymphomas. However, they have not been as effective against solid tumors because they become hyporesponsive (“exhausted” or “dysfunctional”) within the tumor microenvironment, with decreased cytokine production and increased expression of several inhibitory surface receptors. Here we define a transcriptional network that mediates CD8 + T cell exhaustion. We show that the high-mobility group (HMG)-box transcription factors TOX and TOX2, as well as members of the NR4A family of nuclear receptors, are targets of the calcium/calcineurin-regulated transcription factor NFAT, even in the absence of its partner AP-1 (FOS-JUN). Using a previously established CAR T cell model, we show that TOX and TOX2 are highly induced in CD8 + CAR + PD-1 high TIM3 high (“exhausted”) tumor-infiltrating lymphocytes (CAR TILs), and CAR TILs deficient in both TOX and TOX2 ( Tox DKO) are more effective than wild-type (WT), TOX-deficient, or TOX2-deficient CAR TILs in suppressing tumor growth and prolonging survival of tumor-bearing mice. Like NR4A-deficient CAR TILs, Tox DKO CAR TILs show increased cytokine expression, decreased expression of inhibitory receptors, and increased accessibility of regions enriched for motifs that bind activation-associated nuclear factor κB (NFκB) and basic region-leucine zipper (bZIP) transcription factors. These data indicate that Tox and Nr4a transcription factors are critical for the transcriptional program of CD8 + T cell exhaustion downstream of NFAT. We provide evidence for positive regulation of NR4A by TOX and of TOX by NR4A, and suggest that disruption of TOX and NR4A expression or activity could be promising strategies for cancer immunotherapy.

19 July 2021 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
HSHyungseok Seo
Hyungseok Seo
EGEdahí González-Avalos
Edahí González-Avalos
WZWade Zhang
Wade Zhang
PRPayal Ramchandani
Payal Ramchandani
CYChao Yang
Chao Yang
PHPatrick G. Hogan
Patrick G. Hogan

10 March 2017 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
GMGiuliana P. Mognol
Giuliana P. Mognol
RSRoberto Spreafico
Roberto Spreafico
VWVictor Wong
Victor Wong
JSJames P. Scott-Browne
James P. Scott-Browne
STSusan Togher
Susan Togher
STSara Trifari
Sara Trifari
Significance: Cancer cells can be recognized and attacked by CD8 + cytolytic T cells, but tumor-infiltrating T cells often become functionally incompetent (“exhausted”) and fail to destroy tumor cells. We show that T-cell exhaustion requires antigen recognition by tumor-infiltrating T cells. By examining the transcriptional and chromatin accessibility profiles of antigen-reactive and -unreactive tumor-infiltrating cells, we confirm our previous conclusion that the transcription factor NFAT promotes CD8 + T-cell exhaustion and we identify Nr4a transcription factors as new targets for future investigation. We show that anti–PD-L1 treatment, a clinically relevant checkpoint blockade therapy that counteracts T-cell exhaustion, has modest but functionally important effects on gene expression in exhausted cells, without causing major changes in patterns of chromatin accessibility.

1 December 2016 in Immunity
Verified
Journal Article
Closed access
JSJames P. Scott-Browne
James P. Scott-Browne
ILIsaac F. López-Moyado
Isaac F. López-Moyado
STSara Trifari
Sara Trifari
VWVictor Wong
Victor Wong
LCLukas Chavez
Lukas Chavez
RPRenata M. Pereira
Renata M. Pereira